Peptide and peptidomimetic inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9644004
SERIAL NO

14962457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RA PHARMACEUTICALS INC87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, Paul Larchmont, US 82 1117
Arata, Michelle Denise Malden, US 3 37
Boyer, Nicolas Cedric Somerville, US 10 49
Elbaum, Daniel Newton, US 61 792
Josephson, Kristopher Wayland, US 18 119
Ma, Zhong Lexington, US 29 121
Nims, Nathan Ezekiel Winchester, US 17 113
Ricardo, Alonso Cambridge, US 40 138
Schneider, Eberhard Denkte, DE 41 327
Schurmann, Gregor Hannover, DE 23 123
Treco, Douglas A Arlington, US 61 964
Wagner, Peter Denkte, DE 213 4266
Wang, Zhaolin Wellesley, US 42 3042
Ye, Ping Lexington, US 31 735
Zheng, Hong Brighton, US 41 195

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 9, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 9, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00